Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by HCallahann44on Dec 24, 2019 2:42pm

149 Views

Post# 30488536

RE:RE:Canadafan --Thx for your input

Thanks Canadafan...the info you provide can simply not be obtained anywhere else...you sound like me with EMX....have owned it forever...studied it to death..met with insiders etc....finally after a lot of fits and starts it is rolling in the right direction. Insiders are loading there too..but the upside is maybe 10 x in a few years rather than a lightening fast move that could happen here. My expertise in the biotech area is very limited...but stumbled on numerous articles about oncy and just starting to study it...sadly it looks like i am late to the game.....when do you anticipate the SOLTI results? thanks so much for what you are doing here

Bullboard Posts

FE Battery Metals begins 2024 winter drill program